The 269-page report was done by a government-appointed panel and calls for limits on COVID-19 vaccines and for health professionals not to be punished for promoting alternative treatments.
Study examines the comparative cardiovascular efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes.